Israel’s Nanoscent has developed a chip, software and sensors that recognize odor and unique disease patterns. It has started a trial at Israel’s Sheba hospital to identify people infected with the coronavirus via a simple 30-second nasal breath test. It could be used at stores, hospitals, and airports.